Arcutis Biotherapeutics, Inc.
NASDAQ:ARQT
14.62 (USD) • At close January 3, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 44.755 | 30.858 | 49.569 | 13.526 | 38.109 | 5.19 | 2.781 | 2.961 | 0.725 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 5.503 | 3.464 | 3.256 | 2.444 | 1.182 | 0.776 | 0.783 | 0.485 | 0.269 | 0.234 | 0.229 | 0.211 | 0.192 | 0.182 | 0.178 | 0.166 | 0 | 0 | 21.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 39.252 | 27.394 | 46.313 | 11.082 | 36.927 | 4.414 | 1.998 | 2.476 | 0.456 | -0.234 | -0.229 | -0.211 | -0.192 | -0.182 | -0.178 | -0.166 | 0 | 0 | -21.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.877 | 0.888 | 0.934 | 0.819 | 0.969 | 0.85 | 0.718 | 0.836 | 0.629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 19.501 | 19.298 | 23.141 | 23.775 | 26.236 | 25.219 | 35.345 | 33.877 | 69.731 | 38.205 | 40.622 | 52.558 | 40.604 | 30.765 | 21.631 | 27.374 | 32.743 | 30.009 | 25.182 | 10.757 | 12.348 | 7.214 | 6.203 | 5.347 | 7.081 | 2.756 | 2.756 |
| General & Administrative Expenses
| 0 | 0 | 0 | 136.471 | 47.595 | 45.958 | 5.791 | 49.628 | 35.473 | 27.622 | 22.006 | 18.728 | 16.474 | 11.315 | 14.454 | 6.69 | 5.56 | 5.618 | 3.469 | 2.237 | 2.3 | 1.324 | 0.749 | 0.606 | 0.614 | 0.288 | 0.288 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -87.995 | 0 | 0 | 37.127 | -12.605 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 58.817 | 58.173 | 54.794 | 48.476 | 47.595 | 45.958 | 42.918 | 37.023 | 35.473 | 27.622 | 22.006 | 18.728 | 16.474 | 11.315 | 14.454 | 6.69 | 5.56 | 5.618 | 3.469 | 2.237 | 2.3 | 1.324 | 0.749 | 0.606 | 0.614 | 0.288 | 0.288 |
| Other Expenses
| 0 | 5.229 | 4.044 | 2.672 | 2.721 | 3.121 | 3.207 | 3.32 | 1.938 | 0.421 | 0.142 | -0.04 | 0.098 | 0.072 | 0.043 | 0.015 | 0.099 | 0.215 | 0.638 | 0.426 | 0.168 | 0.248 | 0.294 | 0.352 | 0 | 0 | 0 |
| Operating Expenses
| 78.318 | 77.471 | 77.935 | 72.251 | 73.831 | 71.177 | 78.263 | 70.9 | 105.204 | 65.827 | 62.628 | 71.286 | 57.078 | 42.08 | 36.085 | 34.064 | 38.303 | 35.627 | 28.651 | 12.994 | 14.648 | 8.538 | 6.952 | 5.953 | 7.642 | 3.006 | 3.006 |
| Operating Income
| -39.066 | -50.077 | -31.622 | -61.169 | -36.904 | -66.763 | -76.265 | -68.424 | -104.748 | -65.827 | -62.628 | -71.286 | -57.078 | -42.08 | -36.085 | -34.064 | -38.303 | -35.627 | -28.651 | -12.994 | -14.648 | -8.538 | -6.952 | -5.953 | -7.695 | -3.044 | -3.044 |
| Operating Income Ratio
| -0.873 | -1.623 | -0.638 | -4.522 | -0.968 | -12.864 | -27.424 | -23.108 | -144.48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -2.471 | -2.255 | -3.436 | -5.09 | -4.838 | -4.228 | -3.835 | -3.595 | -2.961 | -1.579 | -1.696 | -0.04 | 0.098 | 0.072 | 0.043 | 0.015 | 0.099 | 0.215 | 0.638 | 0.426 | 0.168 | 0.248 | 0.294 | 0.352 | 0.02 | 0.054 | 0.054 |
| Income Before Tax
| -41.537 | -52.332 | -35.058 | -66.259 | -41.742 | -70.991 | -80.1 | -72.019 | -107.709 | -67.406 | -64.324 | -71.326 | -56.98 | -42.008 | -36.042 | -34.049 | -38.204 | -35.412 | -28.013 | -12.568 | -14.48 | -8.29 | -6.658 | -5.601 | -7.675 | -2.99 | -2.99 |
| Income Before Tax Ratio
| -0.928 | -1.696 | -0.707 | -4.899 | -1.095 | -13.678 | -28.803 | -24.323 | -148.564 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.324 | 0.025 | 3.023 | 10.084 | -0.363 | 3.595 | 2.961 | 1.579 | 1.696 | -0.136 | -0.076 | -0.078 | -0.098 | -0.131 | 0 | 0.008 | 0 | 0 | 0 | 0 | 0 | -5.953 | 0.02 | 0.054 | 0.054 |
| Net Income
| -41.537 | -52.332 | -35.382 | -66.284 | -44.765 | -70.991 | -79.737 | -75.614 | -110.67 | -68.985 | -66.02 | -71.326 | -56.98 | -42.008 | -36.042 | -34.049 | -38.204 | -35.412 | -28.013 | -12.568 | -14.48 | -8.29 | -6.658 | -5.601 | -7.675 | -2.99 | -2.99 |
| Net Income Ratio
| -0.928 | -1.696 | -0.714 | -4.9 | -1.175 | -13.678 | -28.672 | -25.537 | -152.648 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.3 | -1.24 | -1.94 | -1.34 | -1.31 | -1.42 | -1.14 | -0.84 | -0.76 | -0.792 | -1.01 | -0.94 | -0.74 | -0.33 | -0.4 | -0.218 | -0.175 | -0.155 | -0.212 | -2.83 | -2.83 |
| EPS Diluted
| -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 | -1.3 | -1.24 | -1.94 | -1.34 | -1.31 | -1.42 | -1.14 | -0.84 | -0.76 | -0.792 | -1.01 | -0.94 | -0.74 | -0.33 | -0.4 | -0.218 | -0.175 | -0.155 | -0.212 | -2.83 | -2.83 |
| EBITDA
| -33.452 | -44.497 | -27.22 | -58.112 | -33.796 | -63.168 | -72.695 | -64.675 | -102.574 | -65.172 | -62.257 | -71.115 | -56.788 | -41.826 | -35.864 | -34.029 | -38.273 | -35.597 | -28.624 | -13.038 | -14.629 | -8.518 | -6.947 | 0 | 0.02 | 0.054 | 0.054 |
| EBITDA Ratio
| -0.747 | -1.611 | -0.631 | -4.494 | -0.897 | -12.262 | -26.27 | -21.987 | -141.418 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |